scispace - formally typeset
M

Mathieu Vinken

Researcher at Vrije Universiteit Brussel

Publications -  257
Citations -  9994

Mathieu Vinken is an academic researcher from Vrije Universiteit Brussel. The author has contributed to research in topics: Connexin & Medicine. The author has an hindex of 45, co-authored 224 publications receiving 8305 citations. Previous affiliations of Mathieu Vinken include Utrecht University & Free University of Brussels.

Papers
More filters
Journal ArticleDOI

Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.

Patricio Godoy, +94 more
TL;DR: This review encompasses the most important advances in liver functions and hepatotoxicity and analyzes which mechanisms can be studied in vitro and how closely hepatoma, stem cell and iPS cell–derived hepatocyte-like-cells resemble real hepatocytes.
Journal ArticleDOI

Alternative (non-animal) methods for cosmetics testing: current status and future prospects—2010

TL;DR: In this paper, Adler et al. present a survey of the authors' work in the field of bioinformatics, including the following authors:Sarah AdlerDavid BasketterStuart CretonOlavi PelkonenJan van BenthemValerie Zuang • Klaus Ejner AndersenAlexandre Angers-LoustauAynur AptulaAnna Bal-PriceEmilio Benfenati • Ulrike BernauerJos BessemsFrederic Y. BoisAlan BoobisEsther BrandonSusanne Bremer • Thomas
Journal ArticleDOI

The adverse outcome pathway concept: A pragmatic tool in toxicology

TL;DR: These newly postulated AOPs can serve a number of ubiquitous purposes, including the establishment of (quantitative) structure-activity relationships, the development of novel in vitro toxicity screening tests and the elaboration of prioritization strategies.
Journal ArticleDOI

Molecular Mechanisms Underlying the Dedifferentiation Process of Isolated Hepatocytes and Their Cultures

TL;DR: Identification of the conditions needed for the full in vitro maturation of hepatic progenitor cells to quiescent, functional hepatocyte-like cells opens promising perspectives.
Journal ArticleDOI

Adverse outcome pathways: opportunities, limitations and open questions.

Marcel Leist, +59 more
TL;DR: The history of the AOP concept and its most prominent strengths are discussed, including the advantages of a formalized approach, the systematic collection of weight of evidence, the linkage of mechanisms to apical end points, the examination of the plausibility of epidemiological data, the identification of critical knowledge gaps and the design of mechanistic test methods.